NASDAQ:PRFX PainReform (PRFX) Stock Price, News & Analysis $0.48 -0.15 (-23.68%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$0.53 +0.05 (+11.39%) As of 11/20/2026 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsNews and TrendsSEC Filings About PainReform Stock (NASDAQ:PRFX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PainReform alerts:Sign Up Key Stats Today's Range$0.46▼$0.6050-Day Range$0.48▼$1.0252-Week Range$0.46▼$7.95Volume69,820 shsAverage Volume276,903 shsMarket Capitalization$1.45 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview PainReform Ltd. is an Israel-based specialty pharmaceutical company developing treatments for postoperative pain. Its lead candidate, PRF-110, is an extended-release formulation of the local anesthetic ropivacaine designed for administration at a surgical site to provide pain relief after surgery. The company’s development work has focused on evaluating PRF-110 for postoperative pain management in procedures including bunion surgery and hernia repair. PainReform’s research centers on drug-delivery approaches intended to extend the effect of local anesthetics.AI Generated. May Contain Errors. Read More PainReform Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScorePRFX MarketRank™: 0.87505258729 of 5 starsPainReform scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingPainReform has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.Amount of Analyst CoveragePainReform has only been the subject of 1 research reports in the past 90 days.Read more about PainReform's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of PainReform is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PainReform is 0.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPainReform has a P/B Ratio of 0.02. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.25% of the float of PainReform has been sold short.Short Interest Ratio / Days to CoverPainReform has a short interest ratio ("days to cover") of 0.39, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in PainReform has recently decreased by 35.90%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPainReform does not currently pay a dividend.Dividend GrowthPainReform does not have a long track record of dividend growth. News and Social MediaN/ANews SentimentN/A Company Ownership1.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PainReform insiders have not sold or bought any company stock.Percentage Held by Insiders34.40% of the stock of PainReform is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions37.28% of the stock of PainReform is held by institutions.Read more about PainReform's insider trading history. Receive PRFX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PainReform and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PRFX Stock News HeadlinesPRF Technologies Receives Nasdaq Delisting Determination Regarding Minimum Bid Price Requirement and Requests a HearingNovember 12, 2026 | globenewswire.comPRF Technologies and Dotz Nano Sign Term Sheet for Strategic Collaboration to Expand AI-Driven Energy Optimization OfferingNovember 3, 2026 | globenewswire.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 22 at 1:00 AM | Base Camp Trading (Ad)PRF Technologies Issues Letter to Shareholders Highlighting $11.0 Million Cash Position, Entering Phase 2 Trial of OcuRing™-K and GridFeed™ Opportunity in AI Data Center PowerOctober 23, 2026 | globenewswire.comPRF Technologies' GridFeed(TM) to Explore Strategic Growth Opportunity in AI Data Center Power OptimizationSeptember 16, 2026 | globenewswire.comPRF Technologies to Establish GridFeed™ as a Standalone Subsidiary to Pursue Strategic Alliances for Its AI-Driven Renewable Energy Trading PlatformSeptember 9, 2026 | globenewswire.comPRF Technologies Provides First Half 2026 Business Update Highlighting Significant Progress Across Healthcare and AI Energy BusinessSeptember 3, 2026 | globenewswire.comPRF Technologies Issues Letter to Shareholders Highlighting Strengthened Financial Position and Building Momentum Across Its Biotechnology and AI-Driven Energy PlatformsJuly 27, 2026 | globenewswire.comSee More Headlines PRFX Stock Analysis - Frequently Asked Questions How have PRFX shares performed this year? PainReform's stock was trading at $3.2090 on January 1st, 2026. Since then, PRFX shares have decreased by 85.2% and is now trading at $0.4758. How were PainReform's earnings last quarter? PainReform Ltd. (NASDAQ:PRFX) issued its quarterly earnings results on Thursday, September, 3rd. The company reported ($1.13) earnings per share for the quarter. The firm had revenue of $7 thousand for the quarter. When did PainReform's stock split? PainReform shares reverse split on the morning of Thursday, November 21st 2024.The 1-4 reverse split was announced on Monday, November 18th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did PainReform IPO? PainReform (PRFX) raised $23 million in an initial public offering (IPO) on Tuesday, September 1st 2020. The company issued 2,550,000 shares at a price of $8.00-$10.00 per share. Maxim Group and Joseph Gunnar acted as the underwriters for the IPO. How do I buy shares of PainReform? Shares of PRFX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PainReform own? Based on aggregate information from My MarketBeat watchlists, some other companies that PainReform investors own include Workhorse Group (WKHS), AMC Entertainment (AMC), Advanced Micro Devices (AMD), Palantir Technologies (PLTR), Tesla (TSLA), Boeing (BA) and Novavax (NVAX). Company Calendar Last Earnings9/03/2026Today11/22/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (4m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 PRFX's financial health is in the Yellow zone, according to TradeSmith. PRFX has been in this zone for over 4 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:PRFX CIK1801834 Webwww.painreform.com Phone972-3717-7051FaxN/AEmployees7Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current Ratio5.07 Quick RatioN/A Sales & Book Value Annual Sales$31 thousand Price / Sales46.69 Cash FlowN/A Price / Cash FlowN/A Book Value$23.07 per share Price / Book0.02Miscellaneous Outstanding Shares3,042,000Free Float1,996,000Market Cap$1.45 million OptionableNot Optionable Beta1.16 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (NASDAQ:PRFX) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredThe warning signs most investors see too lateDr. Martin D. Weiss has publicly predicted six major American crashes since founding Weiss Ratings in 1971. ...Weiss Ratings | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PainReform Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share PainReform With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.